This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Cell & Gene Therapy Manufacturing & Commercialization US

Early Registration Savings Deadline Expires In

  • 00
  • 00
  • 00
  • 00
Delivered as a Hybrid Event
September 27-30, 2022Boston Convention and Exhibition Center

Polyplus Transfection


Polyplus-transfection applies its 20 years expertise to the development of novel transfection solutions, especially for viral vectors manufacturing for Gene & Cell Therapy. We are proud to provide the gold standard PEIpro, as well as the novel game changer FectoVIR-AAV, specifically designed for AAV production in suspension cells. Both reagents are available at RUO and GMP-grades, making them suitable from R&D to clinical trial and commercial scale, accompanied by a strong scientific and regulatory support.